Have you ever searched for something and had to go through many cumbersome websites, only to come away with very limited information? That frustrating cycle of clicking, scanning, and second-guessing sources is all too familiar to most of us, whether you are a researcher, a regulator, in the private sector, or a general biotech stakeholder. It is also what trying to understand biotechnology and genetically modified (GM) crops can feel like for someone not in the field at all. Credible, up-to-date information is often scattered, difficult to interpret, and sometimes inaccessible to the very people who need it most.
This is what makes having a credible database like Biotech Africa feel immediately useful. It brings together information that would normally sit across multiple platforms and presents it in an easily understandable and relatable format in one place. For researchers, regulators, and even private sector actors, that kind of centralisation matters. Decisions in biotechnology are rarely made in isolation. They rely on knowing what has already been approved, what regulatory processes exist, and what other countries are doing. Without that, you are not just uninformed; you are essentially operating at a disadvantage.
In that sense, the database is more than just a collection of facts. It has the potential to support transparency. When regulatory approvals, requirements, and decision documents are easier to find, it becomes harder to operate behind closed doors. That visibility encourages accountability and, in most cases, builds trust. It also allows countries to learn from one another, instead of duplicating efforts or repeating mistakes.
There is also a practical dimension that is so easy to overlook. Technology does not move freely if information does not. For biotech crops to be developed, approved and eventually traded, there needs to be clarity around regulatory environments. A centralised source of information can reduce uncertainty for developers and investors, making it easier to move from research to actual deployment. In regions where agricultural innovation is urgently needed, that is not a small contribution.
Looking at the agricultural landscape of Africa through the lens of Biotech Africa offers an especially interesting perspective. Agriculture on the continent is not just an economic sector; it is directly tied to food security, livelihoods, and resilience in the face of changing climate conditions. One detail that stands out from the database is how limited the current footprint of
GM crops in Africa still is, with only a handful of crops reflected. The introduction of a new crop variety can influence yields, pest management, input costs, and even market access. When countries and institutions have access to reliable, centralised information, they are better positioned to weigh these factors carefully. It also reveals Africa is not defined by a single approach, but by a range of responses to biotechnology. Some countries are advancing quickly, having the full range of field trials, commercial releases, and approvals for import of crops for food, feed and processing (FFP); others are taking a more gradual path, and many are finding a balance between different priorities.
Perhaps most importantly, improved access to information helps shift the conversation itself. Instead of relying on assumptions or incomplete knowledge, discussions around GM products can become more grounded. This does not mean everyone will agree, but it does mean that decisions are more likely to be informed by evidence.
In that sense, the value of Biotech Africa lies not just in what it contains, but in what it enables. It supports a more transparent regulatory environment, encourages regional learning, and provides a stronger foundation for responsible agri-biotech development. Of course, no single platform can answer every question or capture every perspective. But by bringing together key information in a clear and accessible way, it makes a meaningful contribution. It helps move the conversation forward, even if it does not define its final direction.
I strongly believe that making information easier to find is not just a simple idea, but an important one. When people have access to reliable knowledge, they are in a better position to make decisions that shape the future of agriculture. Biotech Africa creates a starting point for more informed, more connected, and ultimately more effective engagement with biotechnology in Africa.
By Daniel Osei Ofosu, Ph.D.
Country Coordinator, Program for Biosafety Systems, Ghana
Biotechnology and Nuclear Agriculture Research Institute
Ghana Atomic Energy Commission